Company Overview and News

0
3 MVPs of the REIT Super Bowl

2018-07-07 investorplace
Each June, the National Association of Real Estate Investment Trusts (NAREIT) hosts a conference that brings all of the key players in the sector together. For REIT investors, it’s the equivalent of the Super Bowl and it offers a window into who’s poised to perform well in the second half of the year and beyond.
SRC SRC.WI SRC.PRA RESI SBRA

18
Once A Month, Realty Income Buys Me Lunch

2018-06-28 seekingalpha
Realty Income (O), has paid consistent monthly dividends for so long it has made its company tag line the "Monthly Dividend Company" and even copyrighted it. As a strong triple net lease REIT or Real Estate Investment Trust, it produces strong ROI by acquiring only the best properties and constantly pruning its portfolio. With its core focus on shareholder dividends being paid and raised, I know my investment is safe.
O.PRF O OPRF STOR SRC NNN.PRD VER SRC.WI NNN.PRF NNN.PRE DG SRC.PRA NNN

6
‘Retail Apocalypse’ Didn’t Scare This Landlord Off an IPO - Bloomberg

2018-06-21 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
SRC SRC.WI EPRT SRC.PRA

13
U.S. IPO Week Ahead: Health Care Deals Lead 11-IPO Week

2018-06-16 seekingalpha
Helped by a strong market, the steady stream of June IPOs should continue in the week ahead with eleven companies scheduled to raise a combined $1.4 billion. SMB payments processor i3 Verticals and triple net lease REIT Essential Properties headline the week, with eight health care deals and a blank check company also expected to price IPOs.
SRC IPO SPOT ARNNY USFD NVS IPOS

59
STORE Capital Corp.: The Warren Buffett REIT

2018-06-15 seekingalpha
Last year, Warren Buffett's Berkshire Hathaway acquired a sizable chunk of stock from STORE Capital Corp. in a private placement.
EPR.PRG O.PRF O OPRF ADC STOR SRC NNN.PRD BRK.A SRC.WI NNN.PRF NNN.PRE EPR SRC.PRA NNN

6
SRC / Spirit Realty Capital, Inc. / FMR LLC / Fidelity - null (Passive Investment)

2018-06-11 sec.gov
SCHEDULE 13G Amendment No. 1 SPIRIT RLTY CAP INC COMMON STOCK Cusip #84860W102 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #84860W102 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 19,183,702 Item 6: 0 Item 7: 52,270,699 Item 8: 0 Item 9: 52,270,699 Item 11: 12.
SRC

6
SRC / Spirit Realty Capital, Inc. / FMR LLC / Fidelity - null (Passive Investment)

2018-06-11 sec.gov
SCHEDULE 13G Amendment No. 1 SPIRIT RLTY CAP INC COMMON STOCK Cusip #84860W102 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #84860W102 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 19,183,702 Item 6: 0 Item 7: 52,270,699 Item 8: 0 Item 9: 52,270,699 Item 11: 12.
SRC

7
SRC / Spirit Realty Capital, Inc. 8-K (Current Report)

2018-06-06 sec.gov
Document UNITED STATES
SRC

6
SRC / Spirit Realty Capital, Inc. 8-K (Current Report)

2018-06-06 sec.gov
Document UNITED STATES
SRC

6
SRC / Spirit Realty Capital, Inc. FORM 8-K (Current Report)

2018-06-05 sec.gov
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549
SRC

6
SRC / Spirit Realty Capital, Inc. FORM 8-K (Current Report)

2018-06-04 sec.gov
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
SRC

8
SRC / Spirit Realty Capital, Inc. FORM 8-K (Current Report)

2018-05-25 sec.gov
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549
SRC

7
SRC / Spirit Realty Capital, Inc. FORM 8-K (Current Report)

2018-05-14 sec.gov
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549
SRC

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to SRC / Spirit Realty Capital, Inc. on message board site Silicon Investor.

Stericycle(SRCL) SRCL: Stericycle, Inc.
Source Media SRCM SRCH: US SEARCH.com Inc.
VSRC: Vsource, Inc. SRCR - Environmental Company
US SEARCH Corp.com (SRCH) Vsource, Inc (VSRC)
vsrc formally ibnl Technisource (TSRC)
CUSIP: 84860W102